Coping behavior in patients with panic disorder

スポンサーリンク

概要

• 論文の詳細を見る
• 2004-04-01

著者

• Fujii Isao

  Department Of Biological Science And Technology Tokai University

• Fujii Isao

  Department Of Neuropsychiatry Oita Medical University

• YAMADA KUMIKO

  Department of Neuropsychiatry, Oita Medical University

• AKIYOSHI JOTARO

  Department of Neuropsychiatry, Oita Medical University

• NAGAYAMA HARUO

  Department of Neuropsychiatry, Oita Medical University

• Yamada Kumiko

  Department Of Neuropsychiatry Oita Medical University

• Nagayama Haruo

  Department Of Neuropsychiatry Oita Medical University

• Akiyoshi Jotaro

  Department Of Neuropsychiatry Oita Medical University

関連論文

• Crystal Structure of α-(p-Methylylamino-ο-nitrobenzyl)pyridine
• Crystal Structure of(p-Amino-o-nitrobenzyl)pyridine
• Crystal Structure of the Antiamnesic Agent α-(p-Butylylamino-o-nitrobenzyl)pyridine
• Crystal Structure of 2-(1-(2, 4-Dinitrobenzoyloxy)ethyl)-3-methyl-4-butanolide
• Crystal Structure of 2-(1-(2,4-Dinitrobenzoyloxy)ethyl)-3-methyl-4-butanolide
• Crystal Structure of 3,4-Diphenyl-N-cyclohexylpyrrole-2,5-dione
• Crystal Structure of 1,3,4-Triphenyl-pyrrole-2,5-dione
• Crystal Structure of 2,5-Bis-(3,5-di-tert-butyl-benzyl)-3,6-bis-(4-dimethylamino-phenyl)-2,5-dihydro-pyrrolo[3,4-c]pyrrole-1,4-dione
• Crystal Structure of 2,5-Bis-(3,5-dimethylbenzyl)-3,6-dinaphthalen-2-yl-2,5-dihydro-pyrrolo[3,4-c]pyrrole-1,4-dione
• Crystal Structure of 3,4-Diphenil-N-(2,6-bis(isopropyl)phenyl)pyrrole-2,5-dione
• Crystal Structure of Tris(8-quinolinolato)aluminum(III)-Ethyl Acetate(1/0.5)
• Strategy to Manage Pump Failure Due to Chronic Pulmonary Diseases : Pathophysiology and Treatment of Right Ventricular Overload : PANEL DISCUSSION ON PUMP FAILURE OF THE HEART WITH COMPLICATIONS : 49th Annual Scientific Session of the Japanese Circulation
• Co-Expression of Yeast Amber Suppressor tRNA^ and Tyrosyl-tRNA Synthetase in Escherichia coli: Possibility to Expand the Genetic Code
• Structure of 3, 5-Cholestadiene-7-one
• Structure of a New Crystal Form of 5-Cholesten-3-β-ol-7-one(7-Ketocholesterol), Form II
• Crystal Structure of 1-{2-[(p-Chloro-α-phenylbenzyl)oxy]ethyl}piperidine Fendizoate (Cloperastine Fendizoate)
• Crystal Structure of Antipsychotic Agent, 1'-[3-(10, 11-dihydro-5H-dibenz[b, f]-azepin-5-yl)propyl][1, 4'-bipiperidine]-4'-carboxamide(Carpipramine)
• Crystal Structure of 6-(o-Chlorophenyl)-8-ethyl-1-methyl-4H-s-triazolo[3, 4-c]thieno[2, 3-e][1, 4]diazepine(Etizolam)
• Crystal Structure of a Potent Pigmentation Agent Trioxsalen
• Relationships between the Molecular Structures and Stabilities of Functional Dyes with a Phenothiazine Skeleton
• Interrupted aortic arch type C associated with DiGeorge syndrome in 22q11.2 deletion : first case detected in Japan
• Crystal Structure of 5,7-Dihydroxy-3-methylcoumarin
• Structure of R-(1-Naphtyl)ethylamine Hydrochloride Monohydrate
• Coping behavior in patients with panic disorder
• Predicting efficacy of electroconvulsive therapy in major depressive disorder
• Discrepancy between subjective and objective sleep in patients with depression

もっと見る 閉じる

スポンサーリンク